BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16771094)

  • 1. [Diffuse idiopathic skeletal hyperostosis and its relation to metabolic parameters].
    Pavelková A; Pavelka K
    Vnitr Lek; 2006 May; 52(5):477-80. PubMed ID: 16771094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis--insulin, insulin-like growth factor-I, growth hormone.
    Denko CW; Boja B; Moskowitz RW
    J Rheumatol; 1994 Sep; 21(9):1725-30. PubMed ID: 7799357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse idiopathic skeletal hyperostosis in diabetes mellitus, impaired glucose tolerance and obesity.
    Coaccioli S; Fatati G; Di Cato L; Marioli D; Patucchi E; Pizzuti C; Ponteggia M; Puxeddu A
    Panminerva Med; 2000 Dec; 42(4):247-51. PubMed ID: 11294086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of axial bone mineral density in postmenopausal women with diffuse idiopathic skeletal hyperostosis related to type 2 diabetes mellitus.
    Sahin G; Polat G; Bagis S; Milcan A; Erdogan C
    J Womens Health (Larchmt); 2002 Nov; 11(9):801-4. PubMed ID: 12626079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone secretion in diffuse idiopathic skeletal hyperostosis.
    Altomonte L; Zoli A; Mirone L; Marchese G; Scolieri P; Barini A; Magarò M
    Ann Ital Med Int; 1992; 7(1):30-3. PubMed ID: 1524945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study.
    Vezyroglou G; Mitropoulos A; Antoniadis C
    J Rheumatol; 1996 Apr; 23(4):672-6. PubMed ID: 8730125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired insulin secretion and uptake in patients with diffuse idiopathic skeletal hyperostosis.
    Eckertova M; Krskova K; Penesova A; Radikova Z; Zlnay D; Rovensky J; Zorad S
    Endocr Regul; 2009 Oct; 43(4):149-55. PubMed ID: 19908933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Forestier disease and metabolism disorders. A prospective controlled study of 25 cases].
    Troillet N; Gerster JC
    Rev Rhum Ed Fr; 1993 Apr; 60(4):274-9. PubMed ID: 8167624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin and new bone formation in diffuse idiopathic skeletal hyperostosis.
    Littlejohn GO
    Clin Rheumatol; 1985 Sep; 4(3):294-300. PubMed ID: 3905220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteoarthritis, insulin and bone density.
    Smythe HA
    J Rheumatol; 1987 May; 14 Spec No():91-3. PubMed ID: 3305943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonarticular tenderness and functional status in patients with diffuse idiopathic skeletal hyperostosis.
    Mader R; Novofastovski I; Rosner E; Adawi M; Herer P; Buskila D
    J Rheumatol; 2010 Sep; 37(9):1911-6. PubMed ID: 20551104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse idiopathic skeletal hyperostosis in ancient clergymen.
    Verlaan JJ; Oner FC; Maat GJ
    Eur Spine J; 2007 Aug; 16(8):1129-35. PubMed ID: 17390155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dystonia and diffuse idiopathic skeletal hyperostosis.
    Chiu HF; Leung J; Li KW
    Singapore Med J; 1991 Feb; 32(1):94-5. PubMed ID: 1673265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffuse interstitial skeletal hyperostosis (DISH) in type 2 diabetes.
    Ghosh B; Kishore S; Vijay V; Ramachandran A
    J Assoc Physicians India; 2004 Dec; 52():994-6. PubMed ID: 15884462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse idiopathic skeletal hyperostosis: a distinct clinical entity.
    Mader R
    Isr Med Assoc J; 2003 Jul; 5(7):506-8. PubMed ID: 12901248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis).
    Sarzi-Puttini P; Atzeni F
    Curr Opin Rheumatol; 2004 May; 16(3):287-92. PubMed ID: 15103260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between monoclonal gammopathy of undetermined significance (MGUS) and diffuse idiopathic skeletal hyperostosis (DISH).
    Scutellari PN; Antinolfi G
    Radiol Med; 2004 Sep; 108(3):172-9. PubMed ID: 15343131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse idiopathic skeletal hyperostosis.
    Rothschild BM
    Compr Ther; 1988 Feb; 14(2):65-9. PubMed ID: 3278841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH).
    Denko CW; Malemud CJ
    Rheumatol Int; 2006 Feb; 26(4):292-7. PubMed ID: 15703952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.